Hercules Capital Inc (HCXY) is a leading publicly traded business development company that specializes in providing financing solutions to growth-stage enterprises, particularly within the life sciences and technology sectors. By offering customized debt and equity financing, Hercules leverages its deep industry knowledge and strategic partnerships to foster innovation and drive value creation. The company's commitment to capital preservation and risk-adjusted returns positions it well for institutional investors seeking diversified exposure to high-growth industries, while its robust investment thesis underscores its capability to identify and support promising organizations in a competitive landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $190.88M |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |